An integrative approach to cancer prevention and treatment can positively transform the health of those affected by this disease. By educating people about lifestyle-based, integrative and scientifically-sound health promotion strategies, we will create deeper and more widespread wellness. More »
Today, Tuesday 1/7 at 2:00 p.m. ET Advocacy Heals U with my co-host Chris Jerry and guest Eva Grayzel who speaks out (and RAPS) about oral cancer, www.W4WN.com and www.W4CS.com.
Anxiety ( blog) and iheart) Hi DR Ryan here, medical oncologist AND PROFESSOR AND RETIRED COLONEL AND CANCER SURVIVOR and this is when tumor is the rumor and cancer is the answer.
http://. https://youtu.be/ovvn2WzyiLs Hi Dr Ryan here, medical oncologist and this is when tumor is the rumor and cancer is the answer. I am sure you are familiar with our opening song from
ATTITUDE Hi dr ryan here, medical oncologist and this is when tumor is the rumor and cancer is the answer. I am sure you are familiar with our opening song from chariots
INTRODUCTION Hi Dr Ryan here Medical oncologist and this is whentumoris the rumorand cancer is the answer I AM SURE YOU ARE FAMILIAR WITH THE SONG FROM CHARIOTS OF FIRE. A MAN
APF530 Superior to Ondansetron in Preventing Chemotherapy-Induced Nausea or Vomiting By Chase Doyle November 25, 2015, Volume 6, Issue 21 Clinical Benefit of APF530 vs Standard of Care The APF530 regimen was
FDA Expands Pembrolizumab Label to Include Approval in Initial Treatment of Unresectable or Metastatic Melanoma
FDA Expands Pembrolizumab Label to Include Approval in Initial Treatment of Unresectable or Metastatic Melanoma By The ASCO Post This is HUGE . Prior to this there really was nothing that worked
Continuous Decline in US Cancer Death Rate: ACS Report Nick Mulcahy The continuous decline in cancer death rates in the United States over the past 2 decades has resulted in an overall
Penn joins groundbreaking cancer research coalition with $250 million grant The Perelman School of Medicine, along with five other peer institutions, has partnered with The Parker Institute for Cancer Immunotherapy to develop